FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386993725> ?p ?o ?g. }

• W4386993725 abstract "Is the psychosocial wellbeing affected in women and men shortly after allocation to a freeze-all strategy with postponement of embryo transfer compared to a fresh transfer strategy?In general, psychosocial wellbeing (i.e. emotional reactions to the treatment, quality-of-life, infertility-related stress, and marital benefit) was similar in women and men allocated to a freeze-all versus those allocated to a fresh-transfer strategy 6 days after disclosure of treatment strategy (i.e. 4 days after oocyte retrieval), although women in the freeze-all group reported a slightly higher degree of depressive symptoms and mood swings compared to women in the fresh transfer group.The use of a freeze-all strategy, i.e. freezing of the entire embryo cohort followed by elective frozen embryo transfer in subsequent cycles has increased steadily over the past decade in assisted reproductive technology (ART). This strategy essentially eliminates the risk of ovarian hyperstimulation syndrome and has proven beneficial regarding some reproductive outcomes in subgroups of women. However, patients experience a longer time interval between oocyte retrieval and embryo transfer, hence a longer time to pregnancy, possibly adding additional stress to the ART treatment. So far, little focus has been on the possible psychosocial strains caused by postponement of embryo transfer.This is a self-reported questionnaire based sub-study of a multicentre randomized controlled trial (RCT) including 460 women and 396 male partners initiating their first, second, or third treatment cycle of invitro fertilisation or intracytoplasmic sperm injection (ICSI) from May 2016 to September 2018. This sub-study was included in the primary project protocol and project plan for the RCT, as psychosocial wellbeing was considered a secondary outcome.Women from eight public fertility clinics in Denmark and Sweden and one private clinic in Spain were randomized in a 1:1 ratio on the day of inclusion (menstrual cycle day 2 or 3) to either a freeze-all strategy with postponement of embryo transfer to a subsequent modified natural menstrual cycle or a fresh transfer strategy with embryo transfer in the hormone stimulated cycle. Treatment allocation was blinded until the day of the ovulation trigger. Women and their male partners were asked to complete a validated self-reported questionnaire 6 days after unblinding of treatment group allocation, corresponding to 4 days after oocyte retrieval, investigating their psychosocial wellbeing related to the treatment defined as emotional reactions to the treatment, quality-of-life, infertility-related stress, and marital benefit. The questionnaire included items from the Copenhagen Multi-Centre Psychosocial Infertility (COMPI) Fertility Problem Stress Scales and the COMPI Marital Benefit Measure.Baseline characteristics were comparable between the two groups for both women and men. In total, response rates were 90.7% for women and 90.2% for men. In the freeze-all group, 207 women and 179 men completed the questionnaire compared with 204 women and 178 men in the fresh transfer group. Men in the two treatment groups did not differ in any of the explored aspects of psychosocial wellbeing (i.e. emotional reactions to the treatment, quality-of-life, infertility-related stress, and marital benefit) 6 days after disclosure of treatment strategy. Women in the freeze-all group reported a slightly higher degree of depressive symptoms (P = 0.045) and mood swings (P = 0.001) (i.e. variables included in 'emotional reactions to treatment') compared to women in the fresh transfer group. When adjusted for multiple testing, depressive symptoms were no longer significantly different between the two groups. No additional differences in psychosocial wellbeing were found. Self-reported quality-of-life during treatment was also rated as similar between the two groups in both women and men, but was slightly lower than they would rate their quality-of-life when not in fertility treatment.Although response rates were high, selection bias cannot be excluded. As this study was an RCT, we assume that psychosocial characteristics of the participants were equally distributed in the two groups, thus it is unlikely that the identified psychosocial differences between the freeze-all and fresh transfer group were present already at baseline. Furthermore, the questionnaire was completed as a one-time assessment 4 days after oocyte retrieval, thus not reflecting the whole treatment process, whereas an assessment after the full completed treatment cycle is needed to draw firm conclusions about the psychosocial consequences of the whole waiting period. However, a question posted that late would be highly biased on whether or not a pregnancy had been achieved.The results indicate that individuals in the freeze-all group exhibited slightly higher levels of depressive symptoms and mood swings compared to those in the fresh transfer group. Nevertheless, it is important to note that any worries related to potential emotional strains stemming from delaying embryo transfer should not overshadow the adoption of a freeze-all approach in cases where it is clinically recommended. As long as patients are provided with comprehensive information about the treatment strategy before initiating the process, it is worth emphasising that other aspects of psychosocial wellbeing were comparable between the two groups.The study is part of the Reprounion collaborative study, co-financed by the European Union, Interreg V Öresund-Kattegat-Skagerrak. L.P. reports financial support from Merck A/S. H.S.N. reports grants from Freya Biosciences ApS, Ferring Pharmaceuticals, BioInnovation Institute, Ministry of Education, Novo Nordic Foundation, Augustinus Fonden, Oda og Hans Svenningsens Fond, Demant Fonden, Ole Kirks Fond and Independent Research Fund Denmark and personal fees from Ferring Pharmaceuticals, Merck A/S, Astra Zeneca, Cook Medical, IBSA Nordic and Gedeon Richter. H.S.N is founder and chairman of the Maternity Foundation and co-developed the Safe Delivery App (non-profit). N.C.F. reports grants from Gedeon Richter, Merck A/S, Cryos International and financial support from Ferring Pharmaceuticals, Merck A/S and Gedeon Richter. N.C.F. is chairman in the steering committee for the guideline groups for The Danish Fertility Society (non-profit). P.H. reports honoraria from Merch A/S, IBSA Nordic and Gedeon Richter. A.L.M.E. reports grants and financial support from Merck A/S and Gedeon Richter. A.P. reports grants from Gedeon Richter, Ferring Pharmaceuticals, Merck A/S and personal fees from Preglem S.A., Novo Nordic Foundation, Ferring Pharmaceuticals, Gedeon Richter, Cryos International, Merch A/S, Theramex and Organon and the lend of embryoscope to the institution from Gedeon Richter. All other authors declare no conflict of interest.Clinicaltrials.gov NCT02746562." @default.
• W4386993725 created "2023-09-25" @default.
• W4386993725 creator A5000419282 @default.
• W4386993725 creator A5002050845 @default.
• W4386993725 creator A5002059944 @default.
• W4386993725 creator A5003105377 @default.
• W4386993725 creator A5006559938 @default.
• W4386993725 creator A5031881637 @default.
• W4386993725 creator A5037649823 @default.
• W4386993725 creator A5045824694 @default.
• W4386993725 creator A5050615514 @default.
• W4386993725 creator A5053992101 @default.
• W4386993725 creator A5063312041 @default.
• W4386993725 creator A5067854671 @default.
• W4386993725 creator A5083506303 @default.
• W4386993725 creator A5085234723 @default.
• W4386993725 creator A5092930022 @default.
• W4386993725 date "2023-09-23" @default.
• W4386993725 modified "2023-09-30" @default.
• W4386993725 title "Psychosocial wellbeing shortly after allocation to a freeze-all strategy compared with a fresh transfer strategy in women and men: a sub-study of a randomized controlled trial" @default.
• W4386993725 cites W1754375904 @default.
• W4386993725 cites W1977484336 @default.
• W4386993725 cites W2027392696 @default.
• W4386993725 cites W2057941571 @default.
• W4386993725 cites W2105540202 @default.
• W4386993725 cites W2107755789 @default.
• W4386993725 cites W2109129651 @default.
• W4386993725 cites W2114599730 @default.
• W4386993725 cites W2132437599 @default.
• W4386993725 cites W2139994810 @default.
• W4386993725 cites W2149309499 @default.
• W4386993725 cites W2150740382 @default.
• W4386993725 cites W2155246851 @default.
• W4386993725 cites W2169784490 @default.
• W4386993725 cites W2274614730 @default.
• W4386993725 cites W2505179618 @default.
• W4386993725 cites W2551416702 @default.
• W4386993725 cites W2555531852 @default.
• W4386993725 cites W2567423128 @default.
• W4386993725 cites W2582792555 @default.
• W4386993725 cites W2741842297 @default.
• W4386993725 cites W2765696959 @default.
• W4386993725 cites W2768309172 @default.
• W4386993725 cites W2903585683 @default.
• W4386993725 cites W2914652649 @default.
• W4386993725 cites W2916002892 @default.
• W4386993725 cites W2916530067 @default.
• W4386993725 cites W3047575149 @default.
• W4386993725 cites W3100377772 @default.
• W4386993725 cites W3119297203 @default.
• W4386993725 cites W3133267463 @default.
• W4386993725 cites W3152925532 @default.
• W4386993725 cites W3157757210 @default.
• W4386993725 cites W3183312070 @default.
• W4386993725 cites W3184069259 @default.
• W4386993725 cites W4225983712 @default.
• W4386993725 cites W4285208352 @default.
• W4386993725 doi "https://doi.org/10.1093/humrep/dead188" @default.
• W4386993725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37742131" @default.
• W4386993725 hasPublicationYear "2023" @default.
• W4386993725 type Work @default.
• W4386993725 citedByCount "0" @default.
• W4386993725 crossrefType "journal-article" @default.
• W4386993725 hasAuthorship W4386993725A5000419282 @default.
• W4386993725 hasAuthorship W4386993725A5002050845 @default.
• W4386993725 hasAuthorship W4386993725A5002059944 @default.
• W4386993725 hasAuthorship W4386993725A5003105377 @default.
• W4386993725 hasAuthorship W4386993725A5006559938 @default.
• W4386993725 hasAuthorship W4386993725A5031881637 @default.
• W4386993725 hasAuthorship W4386993725A5037649823 @default.
• W4386993725 hasAuthorship W4386993725A5045824694 @default.
• W4386993725 hasAuthorship W4386993725A5050615514 @default.
• W4386993725 hasAuthorship W4386993725A5053992101 @default.
• W4386993725 hasAuthorship W4386993725A5063312041 @default.
• W4386993725 hasAuthorship W4386993725A5067854671 @default.
• W4386993725 hasAuthorship W4386993725A5083506303 @default.
• W4386993725 hasAuthorship W4386993725A5085234723 @default.
• W4386993725 hasAuthorship W4386993725A5092930022 @default.
• W4386993725 hasConcept C118552586 @default.
• W4386993725 hasConcept C131872663 @default.
• W4386993725 hasConcept C141071460 @default.
• W4386993725 hasConcept C144133560 @default.
• W4386993725 hasConcept C150966472 @default.
• W4386993725 hasConcept C15744967 @default.
• W4386993725 hasConcept C160099875 @default.
• W4386993725 hasConcept C162853370 @default.
• W4386993725 hasConcept C168563851 @default.
• W4386993725 hasConcept C2777688143 @default.
• W4386993725 hasConcept C2778278907 @default.
• W4386993725 hasConcept C2779234561 @default.
• W4386993725 hasConcept C2779466795 @default.
• W4386993725 hasConcept C2908647359 @default.
• W4386993725 hasConcept C29456083 @default.
• W4386993725 hasConcept C500014431 @default.
• W4386993725 hasConcept C512716672 @default.
• W4386993725 hasConcept C518429986 @default.
• W4386993725 hasConcept C54355233 @default.
• W4386993725 hasConcept C71924100 @default.
• W4386993725 hasConcept C86803240 @default.
• W4386993725 hasConcept C99454951 @default.

• next